Discover 870 paid clinical trials in Tuscaloosa, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 870
KRT-232 in Combination With TL-895 for the Treatment of R/R MF and KRT-232 for the Treatment of JAKi Intolerant MF
for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Birmingham AL, Lake City FL, Urbana IL, New York NY,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT04640532
Phase 1, Phase 2, Recruiting
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
for
Non-cystic Fibrosis Bronchiectasis
Location: Birmingham AL, Atlanta GA, Franklin TN, Augusta GA,
Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
Sex: All
Age: 18 - 70+
Code: NCT06559150
Phase 2, Recruiting
Prehabilitation Feasibility Among Older Adults Undergoing Transplantation
for
Multiple Myeloma
Location: Birmingham AL
Sponsor: Noha Mohamed Sharafeldin
Sex: All
Age: 60+
Code: NCT05642884
Recruiting
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness
for
Breast Cancer
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: Female
Age: 18+
Code: NCT03321045
Early Phase 1, Recruiting
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
for
Clear Cell Renal Cell Carcinoma, Solid Tumors
Location: Birmingham AL, Atlanta GA, Nashville TN, New Orleans LA,
Sponsor: Arcus Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT05536141
Phase 1, Recruiting
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
for
Hepatocellular Carcinoma (HCC)
Location: Birmingham AL, Lexington KY, St Louis MO,
Sponsor: RayzeBio, Inc.
Sex: All
Age: 18+
Code: NCT06726161
Phase 1, Phase 2, Recruiting
A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areata
for
Alopecia Areata
Location: Birmingham AL, Louisville KY, Charlotte NC,
Sponsor: AnaptysBio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT05205070
Phase 2, Recruiting
A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
for
Dystonia
Location: Birmingham AL, Memphis TN, Atlanta GA, Nashville TN,
Sponsor: Vima Therapeutics
Sex: All
Age: 18 - 70
Code: NCT07304089
Phase 2, Recruiting
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
for
Growth Hormone Deficiency (GHD)
Location: Birmingham AL, New Orleans LA, Tallahassee FL,
Sponsor: Lumos Pharma
Sex: All
Age: 3 - 11
Code: NCT06948214
Phase 3, Recruiting
An Open-label Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome
for
Phelan-McDermid Syndrome
Location: Birmingham AL, Cincinnati OH, Houston TX, Chicago IL,
Sponsor: Neuren Pharmaceuticals Limited
Sex: All
Age: 3 - 12
Code: NCT07593391
Phase 3, Recruiting
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
for
Atrial Fibrillation (AF)
Location: Birmingham AL, Mobile AL, Chattanooga TN, Pensacola FL,
Sponsor: Anthos Therapeutics, Inc.
Sex: All
Age: 65+
Code: NCT05712200
Phase 3, Recruiting
Regulation of Inflammatory Genes in Hidradenitis Suppurativa